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Abstract
Extracellular accumulation of amyloid-β (Aβ) peptide and death of neurons in brain regions involved in
learning and memory, particularly the cortex and the hippocampus, are central features of Alzheimer’s disease
(AD). Neuronal Ca2+ overload and apoptosis are known to occur in AD. Aβ might play a role in disrupting Ca2+
homeostasis, and this AD-associated amyloidogenic peptide has been reported to induce apoptotic death in
cultured cells. However, the specific intracellular signaling pathways by which Aβ triggers cell death are not
yet well defined. This article provides evidence for the involvement of mitochondrial dysfunction in Aβ-induced
toxicity and for the role of mitochondria in apoptosis triggered by Aβ. In addition, the endoplasmic reticulum
(ER) seems to play a role in Aβ-induced apoptotic neuronal death, the ER stress being mediated by the pertur-
bation of ER Ca2+ homeostasis. It is likely that a better understanding of how Aβ induces neuronal apoptosis
will lead to the identification of potential molecular targets for the development of therapies for AD.
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Alzheimer’s Disease
and Amyloid-β Peptide
Alzheimer’s disease (AD) is the most common
form of dementia in the elderly, the prevalence of
which increases exponentially with aging. Clinically,
this neurodegenerative disease of the central ner-
vous system is characterized by the progressive loss
of memory, by cognitive and language impairment,
and also by behavioral disturbances. These clinical
features are accompanied by characteristic histo-
logical changes in the brain (especially in the
cerebral cortex), which include the presence of extra-
cellular senile plaques, intraneuronal neurofibrillary
tangles mainly composed of hyperphosphorylated
tau, and the loss of synapses and neurons (Yankner,
1996). The amyloid-β (Aβ) peptide is a major com-
ponent of the extracellular senile plaque, which
naturally arises from the metabolic processing of
the amyloid precursor protein (APP) in the endo-
plasmic reticulum (ER), the Golgi apparatus, or the
endosomal-lysosomal pathway and is normally
secreted as a 40 (Aβ1-40)- or 42 (Aβ1-42)-amino-acid
peptide (Haass and Selkoe, 1993). Amyloid precur-
sor protein (APP) is initially cleaved by either β- or
α-secretases, leading to the generation of C-terminal
membrane-bound fragments, which are immediate
substrates for cleavage by γ-secretase to liberate Aβ
(β- and γ-secretase) or a smaller peptide termed p3
(α- and γ-secretase cleavage). The Aβ1-40 and Aβ1-42
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